| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ART.23204 |
| P698 | PubMed publication ID | 18240232 |
| P50 | author | Dafna D. Gladman | Q37605821 |
| P2093 | author name string | Earl D Silverman | |
| Hermine I Brunner | |||
| Dominique Ibañez | |||
| Murray D Urowitz | |||
| P433 | issue | 2 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| P304 | page(s) | 556-562 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus | |
| P478 | volume | 58 |
| Q50974310 | Activity of childhood lupus nephritis is linked to altered T cell and cytokine homeostasis. |
| Q27690838 | Adult outcomes of childhood-onset rheumatic diseases |
| Q39010807 | Advances in the care of children with lupus nephritis |
| Q54987715 | Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate. |
| Q39178596 | Age of onset influences on clinical and laboratory profile of patients with systemic lupus erythematosus |
| Q40299868 | Age-related differences in the clinical characteristics of systemic lupus erythematosus in children |
| Q88468246 | American College of Rheumatology Provisional Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus |
| Q92314304 | An Overview of the Intrinsic Role of Citrullination in Autoimmune Disorders |
| Q37166730 | An unusual presentation of lupus in a pediatric patient. |
| Q34983538 | Analysis of gender differences in genetic risk: association of TNFAIP3 polymorphism with male childhood-onset systemic lupus erythematosus in the Japanese population |
| Q48361761 | Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus. |
| Q38679869 | Assessment of condyle, masseter and temporal muscles volumes in patients with juvenile systemic lupus erythematosus: A cross-sectional study. |
| Q35184749 | Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups |
| Q36375184 | Association of miRNA-145 expression in vascular smooth muscle cells with vascular damages in patients with lupus nephritis |
| Q22299246 | Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus |
| Q35825371 | Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus |
| Q37167062 | Biomarkers and updates on pediatrics lupus nephritis |
| Q35810911 | Biomarkers for kidney involvement in pediatric lupus |
| Q37552142 | Biomarkers for renal disease in childhood |
| Q39043287 | Challenges of Diagnosing Cognitive Dysfunction With Neuropsychiatric Systemic Lupus Erythematosus in Childhood. |
| Q57467570 | Child-onset systemic lupus erythematosus is associated with a higher incidence of myopericardial manifestations compared to adult-onset disease |
| Q51545862 | Childhood lupus: Experience from Eastern India |
| Q39067278 | Childhood versus adult-onset systemic lupus erythematosus: long-term outcome and predictors of mortality. |
| Q37127464 | Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus |
| Q33755568 | Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry IX: Clinical Features and Survival of Childhood-Onset Systemic Lupus Erythematosus in China |
| Q38153171 | Chorea, a little-known manifestation in systemic lupus erythematosus: short literature review and four case reports |
| Q48413419 | Clinical and laboratory variables of childhood systemic lupus erythematosus in western province of Saudi Arabia |
| Q35743904 | Clinical and serological manifestations associated with interferon-α levels in childhood-onset systemic lupus erythematosus |
| Q86015625 | Clinical applications of the indirect immunofluorescence assay for detection of anticell membrane-associated DNA antibodies in juvenile systemic lupus erythematosus |
| Q31058821 | Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register. |
| Q42019937 | Clinical features and mortality in Chinese with lupus nephritis and neuropsychiatric lupus: A 124-patient study |
| Q50285114 | Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study |
| Q34610794 | Clinical presentations and outcomes of Filipino juvenile systemic lupus erythematosus |
| Q92615904 | Comparison of Clinical and Laboratory Findings in Patients with Systemic Lupus Erythematosus with Regard to Age at Onset |
| Q37007652 | Current perspectives on ophthalmic manifestations of childhood rheumatic diseases |
| Q34095231 | Cyclophosphamide and lupus nephritis: when, how, for how long? |
| Q33653385 | Cytokine profile in childhood-onset systemic lupus erythematosus: a cross-sectional and longitudinal study |
| Q92956821 | Cytomegalovirus antigenemia in patients with autoimmune and non-autoimmune diseases in Beijing: A 10-year single hospital experience |
| Q37475947 | Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index |
| Q35680302 | Damage index in childhood-onset systemic lupus erythematosus in Egypt. |
| Q38763655 | Delays to care in pediatric lupus patients from the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry |
| Q89316084 | Depression and medication nonadherence in childhood-onset systemic lupus erythematosus |
| Q40038921 | Differences in clinical features observed between childhood-onset versus adult-onset systemic lupus erythematosus: A systematic review and meta-analysis |
| Q33431990 | Differences in disease phenotype and severity in SLE across age groups |
| Q33871944 | Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus |
| Q98578405 | Disease-associated and patient-specific immune cell signatures in juvenile-onset systemic lupus erythematosus: patient stratification using a machine-learning approach |
| Q34554770 | Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients |
| Q33725656 | Educational and vocational outcomes of adults with childhood- and adult-onset systemic lupus erythematosus: nine years of followup |
| Q35007931 | Effects of obesity on health-related quality of life in juvenile-onset systemic lupus erythematosus |
| Q35082426 | End-stage renal disease due to lupus nephritis among children in the US, 1995-2006. |
| Q37778652 | Epidemiologic, socioeconomic and psychosocial aspects in lupus erythematosus |
| Q48617296 | Evaluation of cardiac functions in juvenile systemic lupus erythematosus with two-dimensional speckle tracking echocardiography. |
| Q39053375 | Evaluation of quality indicators and disease damage in childhood-onset systemic lupus erythematosus patients |
| Q55112474 | Final adult height of patients with childhood-onset systemic lupus erythematosus: a cross sectional analysis. |
| Q47939662 | Flares in Chinese systemic lupus erythematosus patients: a 6-year follow-up study |
| Q47383976 | High Health Care Utilization Preceding Diagnosis of Systemic Lupus Erythematosus in Youth. |
| Q38210271 | High-mobility group box 1 (HMGB1) in childhood: from bench to bedside |
| Q37211247 | How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets |
| Q37342980 | Hypogammaglobulinemia in pediatric systemic lupus erythematosus |
| Q58795695 | Improvement of survival rates in the last decade in Thai childhood-onset systemic lupus erythematosus |
| Q30832692 | Improving care delivery and outcomes in pediatric rheumatic diseases |
| Q35911531 | Inactive disease and remission in childhood-onset systemic lupus erythematosus |
| Q87755613 | Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus |
| Q35426946 | Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in juvenile-onset systemic lupus erythematosus |
| Q26825971 | Infections and Systemic Lupus Erythematosus: Binding or Sparring Partners? |
| Q42220143 | Infections and systemic lupus erythematosus |
| Q33428244 | Isolated thrombocytopenia; A report of a rare presentation of childhood systemic lupus erythematosus (SLE). |
| Q36302245 | Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis |
| Q44593708 | Juvenile and adult-onset systemic lupus erythematosus: an ethnicity-based comparison. |
| Q36552283 | Juvenile systemic lupus erythematosus onset patterns in Vietnamese children: a descriptive study of 45 children |
| Q36702788 | Juvenile systemic lupus erythematosus with primary neuropsychiatric presentation |
| Q26849746 | Juvenile systemic lupus erythematosus: review of clinical features and management |
| Q57167326 | Long-term clinical outcomes in a cohort of adults with childhood-onset Systemic Lupus Erythematosus |
| Q44729424 | Long-term follow-up of autologous stem cell transplantation for severe paediatric systemic lupus erythematosus |
| Q92354998 | Management of refractory lupus nephritis: challenges and solutions |
| Q34046983 | Minimal clinically important differences of disease activity indices in childhood-onset systemic lupus erythematosus. |
| Q34937950 | Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature |
| Q34307491 | Neurocognitive deficits and neuroimaging abnormalities are prevalent in children with lupus: clinical and research experiences at a US pediatric institution |
| Q34310715 | Neurologic manifestations of systemic lupus erythematosus in children and adults |
| Q34720014 | Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity |
| Q89484853 | Patterns of Health Care Utilization and Medication Adherence Among Youth with Systemic Lupus Erythematosus During Transfer from Pediatric to Adult Care |
| Q37850999 | Pediatric SLE--towards a comprehensive management plan |
| Q55387947 | Pediatric Systemic Lupus Erythematosus: Learning From Longer Follow Up to Adulthood. |
| Q91715407 | Pediatric antiphospholipid syndrome |
| Q37800298 | Pediatric lupus in Asia |
| Q33723511 | Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? |
| Q38771936 | Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus |
| Q36903365 | Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus |
| Q35738664 | Predictors of kidney disease in a cohort of pediatric patients with lupus |
| Q47807744 | Pregnancy outcomes in women with childhood-onset and adult-onset systemic lupus erythematosus: a comparative study |
| Q35199345 | Preliminary criteria for global flares in childhood-onset systemic lupus erythematosus |
| Q37777642 | Prevalence and burden of pediatric-onset systemic lupus erythematosus |
| Q36587996 | Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population |
| Q34157817 | Prospective validation of the provisional criteria for the evaluation of response to therapy in childhood-onset systemic lupus erythematosus |
| Q90590511 | Protecting the kidney in systemic lupus erythematosus: from diagnosis to therapy |
| Q38374309 | Reviewing the recommendations for lupus in children |
| Q37272264 | Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices |
| Q33411406 | Safety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus |
| Q37328887 | Serum IL-18 as biomarker in predicting long-term renal outcome among pediatric-onset systemic lupus erythematosus patients. |
| Q47267579 | Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus |
| Q88551313 | Spectrum of systemic lupus erythematosus in Oman: from childhood to adulthood |
| Q87203784 | Studying IFN-gamma, IL-17 and FOXP3 in pediatric lupus nephritis |
| Q55282858 | Systemic Lupus Erythematosus in Primary Care: An Update and Practical Messages for the General Practitioner. |
| Q36295937 | Taxonomy for systemic lupus erythematosus with onset before adulthood |
| Q40283637 | The Role of MicroRNAs and Human Epidermal Growth Factor Receptor 2 in Proliferative Lupus Nephritis |
| Q89143768 | The Spectrum of Biopsy-Proven Glomerular Diseases among Children in China: A National, Cross-Sectional Survey |
| Q34576314 | The clinical significance of vitamin D in systemic lupus erythematosus: a systematic review |
| Q91915080 | The impact of antiphospholipid antibodies in children with lupus nephritis |
| Q37504701 | The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus |
| Q34626276 | Toward the development of criteria for global flares in juvenile systemic lupus erythematosus |
| Q37690103 | Update on differences between childhood-onset and adult-onset systemic lupus erythematosus |
| Q52670608 | Urinary clusterin-a novel urinary biomarker associated with pediatric lupus renal histopathologic features and renal survival. |
| Q42947364 | Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis |
| Q38163393 | Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study |
| Q38010347 | Urine biomarkers in juvenile-onset SLE nephritis |
| Q33818710 | Use of atorvastatin in systemic lupus erythematosus in children and adolescents |
| Q88454002 | Use of echocardiography at diagnosis and detection of acute cardiac disease in youth with systemic lupus erythematosus |
| Q51103481 | Vitamin D status in children with systemic lupus erythematosus and its association with clinical and laboratory parameters. |
Search more.